Allarity Therapeutics, Inc. (ALLR) shareholders
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| John M. Fife | 8,999,800 | – | 13G (passive) | Aug 19, 2024 |
| Olmsted Investments LLC | 10,000 | 28.60% | 13G (passive) | Aug 19, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ALLR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 331,509 | 2.08% | $427.65K | +103,425 | 0.00% |
| Vanguard Capital Management LLC | 171,795 | 1.08% | $221.62K | – | 0.00% |
| Geode Capital Management, LLC | 154,867 | 0.97% | $199.78K | −35,526 | 0.00% |
| State Street Corp | 137,600 | 0.86% | $177.50K | – | 0.00% |
| Militia Capital Management LLC | 98,978 | 0.62% | $127.68K | New | 0.00% |
| Citadel Advisors LLC | 91,748 | 0.58% | $118.36K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 74,913 | 0.47% | $96.64K | – | 0.00% |
| Hrt Financial LP | 37,003 | 0.23% | $47.00K | New | 0.00% |
| Northern Trust Corp | 36,534 | 0.23% | $47.13K | −11,569 | 0.00% |
| Jane Street Group, LLC | 36,021 | 0.23% | $46.47K | New | 0.00% |
| Two Sigma Investments, LP | 27,492 | 0.17% | $35.47K | – | 0.00% |
| UBS Group AG | 26,589 | 0.17% | $34.30K | +3,431 | 0.00% |
| XTX Topco Ltd | 20,884 | 0.13% | $26.94K | −8,083 | 0.00% |
| Susquehanna International Group, Llp | 17,221 | 0.11% | $22.22K | New | 0.00% |
| Virtu Financial LLC | 15,322 | 0.10% | $20.00K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 2,650 | 0.02% | $3.42K | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 22 | 0.00% | $28 | +21 | 0.00% |
| FMR LLC | 13 | 0.00% | $17 | New | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $1 | – | 0.00% |
| Jones Financial Companies Lllp | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 20 | 1M | 8.1% | 8 / 3 | 3 / 2 | 0M | 0M |
| Q1 2026 | 14 | 1M | 6.0% | 5 / 2 | 4 / 6 | 0M | 0M |
| Q4 2025 | 16 | 1M | 8.1% | 6 / 4 | 3 / 1 | 1M | 0M |
| Q3 2025 | 11 | 1M | 6.5% | 7 / 1 | 1 / 6 | 1M | 0M |
| Q2 2025 | 10 | 0M | 1.2% | 4 / 3 | 1 / 3 | 0M | 0M |
| Q1 2025 | 9 | 0M | 0.6% | 6 / 2 | 0 / 3 | 0M | 0M |
| Q4 2024 | 6 | 0M | 0.7% | 3 / 2 | 1 / 1 | 0M | 0M |
| Q3 2024 | 4 | 0M | 0.1% | 4 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held ALLR in Q2 2026, 55% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ALLR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 171,795 | 1.08% | $221.62K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 94,289 | 0.59% | $154.63K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 22,166 | 0.14% | $36.35K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 21,595 | 0.14% | $35.42K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jeremy R. Graff | See Remarks | 80,095 | 0.50% | Oct 9, 2026 |
| Thomas Jensen | CEO | 596,734 | 3.75% | May 14, 2026 |
| Jeffrey S. Ervin | CFO | 150,000 | 0.94% | Apr 30, 2026 |
| Alexander Epshinsky | CFO | 85,051 | 0.53% | Jan 24, 2025 |
| Jesper Hoeiland | Director | 25,000 | 0.16% | May 11, 2026 |
| Gerald W. McLaughlin | Director | 70,000 | 0.44% | May 7, 2026 |
| Laura Benjamin | Director | – | – | Jan 24, 2025 |
| Joseph Walter Vazzano | Director | – | – | Jan 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jeremy R. Graff See Remarks | Sep 30, 2026 | Tax withholding | −14,613 | $0.97 | $14.17K | 80,095 |
| Jeremy R. Graff See Remarks | Sep 30, 2026 | Option exercise | +39,494 | – | – | 94,708 |
| Thomas Jensen CEO | Jan 28, 2026 | Award | +200,000 | – | – | 596,734 |
| Gerald W. McLaughlin Director | Jan 28, 2026 | Award | +45,000 | – | – | 70,000 |
| Jeffrey S. Ervin CFO | Jan 28, 2026 | Award | +150,000 | – | – | 150,000 |
| Jeremy R. Graff See Remarks | Jan 28, 2026 | Award | +133,333 | – | – | 381,644 |
| Jeremy R. Graff See Remarks | Jan 22, 2026 | Tax withholding | −17,814 | $1.18 | $21.02K | 55,214 |
| Jeremy R. Graff See Remarks | Jan 22, 2026 | Option exercise | +48,147 | – | – | 73,028 |
| Jesper Hoeiland Director | Jan 7, 2026 | Award | +25,000 | – | – | 25,000 |
| Jeremy R. Graff See Remarks | Jan 7, 2026 | Award | +133,333 | – | – | 381,644 |
| Jeremy R. Graff See Remarks | Sep 30, 2025 | Tax withholding | −14,613 | $1.58 | $23.09K | 24,881 |
| Jeremy R. Graff See Remarks | Sep 30, 2025 | Option exercise | +39,494 | – | – | 39,494 |
| Jeremy R. Graff CDO | Jan 22, 2025 | Award | +144,441 | – | – | 262,924 |
| Alexander Epshinsky CFO | Jan 22, 2025 | Award | +29,496 | – | – | 85,051 |
| Thomas Jensen CEO | Jan 22, 2025 | Award | +396,734 | – | – | 396,734 |
| Jeremy R. Graff See Remarks | Sep 30, 2024 | Award | +118,483 | $2.11 | $250.00K | 118,483 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Allarity Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,900 shares on Oct 13, 2026 over the last 90 days.
See a number that looks wrong?